Global team uncovers genomic secrets behind varied incidence in kidney cancer rates
In a landmark paper published today (1 May, 2024) by the Mutographs team in Nature, they identify new mutational signatures at play in the development of clear cell renal cell carcinoma, of unknown origin, which contribute towards…
In 2017, the IMAXT team was awarded £20 million by Cancer Grand Challenges, funded by Cancer Research UK.
Through the Cancer Grand Challenges initiative, a global team of experts from fields as diverse as medicine,…
We’re leading a global conversation to help shape our next round of funding, inviting the submission of ideas via our Online Ideas Portal from now until 28 November.
Here, Sheona Scales, Head of Research at Cancer…
How a suite of advanced machine learning algorithms is finding new cancer-causing patterns of DNA damage
Cancer Grand Challenges researchers and collaborators have identified four new mutational signatures, including a…
Advocacy plays a major role in Cancer Grand Challenges. The team taking on our Solid Tumours in Children challenge includes six advocates, representing the voice of children and families affected by solid cancers and…
Today we launch Discover: a year of scientific creativity – our annual progress magazine showcasing the power of global team science. Discover celebrates how our community is coming together, thinking differently and…
From the team taking on our Cancer Causes challenge, a new integrated atlas of the stromal and epithelial interactions that drive cancers associated with chronic inflammation provides a new way to understand cancer…
Meet the global network of early-career researchers driving the development of cancer’s most intricate maps, as part of our 3D Tumour Mapping challenge.
The tumour ecosystem, a web of interactions between the tumour’…
Non-invasive breast carcinomas have long been assumed to be the precursors of any invasive cancers that follow. But new findings, from the team taking on our Lethal vs Non-lethal challenge, indicate that around 1 in 5…
Colorectal cancer incidence is increasing worldwide, particularly in people younger than 50 years, but the reason remains a mystery. In addition, the effectiveness of treatments inexplicably varies within the same…